Trust Biomed Ltd (TBL) is a Zambian pharmaceutical company. TBL has developed, tested, and obtained final approval for a ground breaking vaccine against Covid 19. The company is now considering launching two variants of the product, an oral one or an injectable. It cannot afford the machinery to manufacture both.
The success of either variant (Variant A or B) is dependent on the actual demand for the product and how long the pandemic persists. Five (05) levels of such demand have been identified (as L1, L2, …L5).
The payoff matrix below provides a summary of the net cashflows (in USD’000 present values) expected to be received on either variant under the respective levels of demand.
L1 |
L2 |
L3 |
L4 |
L5 |
|
Variant A |
2,000 |
2,500 |
3,000 |
3,500 |
4,000 |
Variant B |
2,500 |
500 |
3,500 |
6,500 |
9,000 |
Prob.- Base |
0.10 |
0.20 |
0.40 |
0.20 |
0.10 |
Prob.- Case 1 |
0.05 |
0.10 |
0.45 |
0.25 |
0.15 |
Prob.- Case 2 |
0.15 |
0.35 |
0.35 |
0.10 |
0.05 |
Required:
Evaluate the decision situation and advise TBL on which product to launch under the Base Case scenario; assuming the presence of Risk takers, Risk averse, and Rational decision makers in the management team.
Demonstrate whether this decision would remain unchanged under either the Case 1 or Case 2 scenarios.
Ans
The Expected Value based on probability of occurence and demand pattern is shown below for base case and case 1 and 2:
Expected Value= where P(xi) is probability of occurence of event xi
L1 | L2 | L3 | L4 | L5 | Expected Value in cashflow for Base Case | Expected Value in cashflow for Case 1 | Expected Value in cashflow for Case 2 | |
Variant A | 2000 | 2500 | 3000 | 3500 | 4000 | 3000 | 3175 | 2775 |
Variant B | 2500 | 500 | 3500 | 6500 | 9000 | 3950 | 4725 | 2875 |
Probability Base | 0.1 | 0.2 | 0.4 | 0.2 | 0.1 | |||
Probability Case 1 | 0.05 | 0.1 | 0.45 | 0.25 | 0.15 | |||
Probability Case 2 | 0.15 | 0.35 | 0.35 | 0.1 | 0.05 |
The excel formulas are shown below:
L1 | L2 | L3 | L4 | L5 | Expected Value in cashflow for Base Case | Expected Value in cashflow for Case 1 | Expected Value in cashflow for Case 2 | |
Variant A | 2000 | 2500 | 3000 | 3500 | 4000 | =E9*E11+F9*F11+G9*G11+H9*H11+I9*I11 | =E9*E12+F9*F12+G9*G12+H9*H12+I9*I12 | =E9*E13+F9*F13+G9*G13+H9*H13+I9*I13 |
Variant B | 2500 | 500 | 3500 | 6500 | 9000 | =E10*E11+F10*F11+G10*G11+H10*H11+I10*I11 | =E10*E12+F10*F12+G10*G12+H10*H12+I10*I12 | =E10*E13+F10*F13+G10*G13+H10*H13+I10*I13 |
Probability Base | 0.1 | 0.2 | 0.4 | 0.2 | 0.1 | |||
Probability Case 1 | 0.05 | 0.1 | 0.45 | 0.25 | 0.15 | |||
Probability Case 2 | 0.15 | 0.35 | 0.35 | 0.1 | 0.05 |
Thus the variant to be launched in base case scenario is Variant B as its expected value is greater than variantA
In both Case 1 and Case2 , I advise launch of Variant B as its Expected value is greater than variant A.
Trust Biomed Ltd (TBL) is a Zambian pharmaceutical company. TBL has developed, tested, and obtained final...
Technovation, Inc., is a major Tier 1 supplier of electrical and electronic parts, with operations in more than 80 countries around the globe. It supplies the parts to Original Equipment Manufacturers (OEMs) in a wide range of industries, including; automotive, aerospace, healthcare, and electronics manufacturing. In the recent past, it has experienced significant growth due to several new contracts received. The company is in the process of identifying suppliers for a critical component that goes into the product it makes....
SYNOPSIS The product manager for coffee development at Kraft Canada must decide whether to introduce the company's new line of single-serve coffee pods or to await results from the product's launch in the United States. Key strategic decisions include choosing the target market to focus on and determining the value proposition to emphasize. Important questions are also raised in regard to how the new product should be branded, the flavors to offer, whether Kraft should use traditional distribution channels or...